Capítulo 4
The Ever-Shifting Cholesterol Hypothesis
The cholesterol hypothesis has undergone constant adaptation to survive contradictory evidence. It began simply: eating too much cholesterol raises blood cholesterol, which deposits on artery walls. When research showed dietary cholesterol doesn't raise blood cholesterol, the hypothesis shifted to blame saturated fat. When it became clear we don't have cholesterol levels but lipoprotein levels, certain lipoproteins were simply renamed "cholesterol."
The hypothesis keeps morphing - first it was saturated fat, then the ratio of polyunsaturated to saturated fat, then a lack of monounsaturated fats. Like a monster from a 1950s horror movie, every time you think it's dead, it just gets stronger.
What's considered "high" cholesterol has been falling relentlessly - from 7.0 mmol/l twenty years ago to 5.0 mmol/l today. Some "experts" believe the true healthy level is 2.5 mmol/l, effectively meaning everyone should be medicated. As Law and Wald (of Polypill fame) argue, everyone in the UK should take statins for life, with some doctors even suggesting "statins in the drinking water."
The diet-heart hypothesis began in mid-19th century Berlin with Rudolf Von Virchow, who discovered cholesterol in arterial plaques and assumed it came from blood. Fifty years later, Russian researcher Nikolai Anitschkov fed rabbits high-cholesterol diets, causing arterial thickening - a fundamentally flawed model since rabbits are herbivores.
Despite early work by Virchow and Anitschkov, the diet-heart hypothesis didn't gain dominance until after WWII. A pivotal moment came in 1954 at a WHO meeting where Ancel Keys boldly presented his dietary hypothesis, only to be challenged by Sir George Pickering to provide a single piece of evidence. Stung by this encounter, Keys launched his famous Seven Countries Study, which showed a correlation between saturated fat consumption, cholesterol levels, and heart disease. Critics note Keys selectively chose countries that supported his hypothesis while ignoring contradictory data from others.
Capítulo 5
The Diet-Heart Hypothesis: A House of Cards
The diet-heart hypothesis has been thoroughly debunked by experts like Professor Michael Oliver and Dr. George Mann. Mann, who studied the Masai villagers of Kenya who consumed extremely high levels of saturated fat yet had virtually zero heart disease, famously called the diet-heart hypothesis "the greatest scam in the history of medicine."
The most damning evidence comes from UK rationing during and after WWII, where 50 million people were placed on a low saturated-fat diet for fourteen years with restricted sausages, eggs, cheese, bacon and milk. Despite this nationwide experiment, heart disease rates nearly tripled during this period - completely contradicting the diet-heart hypothesis.
The French consume more saturated fat than any other European nation yet have one-quarter the heart disease rate of the UK. Similarly, Switzerland has the second-highest saturated fat consumption and nearly as low heart disease rates. Claims that garlic, red wine, and lightly cooked vegetables protect the French are unsupported by evidence - these are merely "ad-hoc hypotheses" invented to protect the diet-heart hypothesis from contradictory evidence.
Israel has one of the highest polyunsaturated to saturated fat ratios in the world, with omega-6 consumption 8% higher than in the USA and 10-12% higher than most European countries. Yet paradoxically, Israelis have high rates of cardiovascular disease, hypertension, diabetes and obesity.
After WWII, saturated fat consumption in Switzerland increased by 20% while heart disease rates fell. Defenders of the diet-heart hypothesis claimed Swiss cows produce cheese high in omega-3 fatty acids, with elaborate explanations about alpine grass-fed cows versus silage-fed cows. This demonstrates researchers' endless ability to invent reasons why paradoxes aren't really paradoxes at all.
In 1988, the US Surgeon General's office began a project to compile all evidence linking saturated fat to heart disease. Eleven years later, they abandoned the project, claiming they "did not anticipate fully the magnitude of additional expertise and staff resources needed." Bill Harlan of the Oversight Committee admitted, "The report was initiated with a preconceived opinion of the conclusions, but the science behind those opinions was clearly not holding up."
Major studies continue to contradict the diet-heart hypothesis. The Malmo study of 28,098 middle-aged Swedes followed for 6.6 years found no relationship between saturated fat intake and cardiovascular disease in men. Among women, cardiovascular mortality actually showed a downward trend with increasing saturated fat intake. The Women's Health Initiative with 48,835 women over 8.1 years found that reducing fat intake (from 37% to 29% of calories) and saturated fat (from 12.4% to 9.5%) produced no significant differences in CHD, stroke incidence, mortality rates, or cancer rates.
Capítulo 6
Debunking the Cholesterol-Heart Disease Connection
Moving beyond diet, let's examine whether cholesterol itself causes heart disease. Strokes and heart disease are both cardiovascular conditions caused by atherosclerotic plaques, yet raised cholesterol isn't a risk factor for stroke. As Japan increased fat consumption between 1958-1999 (from 5% to 20% of calories), cholesterol levels rose from 3.9 to 4.9mmol/l. Remarkably, during this period, stroke mortality in Japanese men aged 60-69 fell dramatically from 1,334 to 226 per 100,000/year - a nearly 6-fold reduction. Heart disease rates also declined despite rising cholesterol levels.
Looking at total mortality reveals even more surprising patterns. Data from the 1992 Conference on Low Blood Cholesterol and Mortality (studying 523,737 men and 124,814 women) showed that for women, the healthiest cholesterol level was around 5.5mmol/l, with mortality increasing at both higher and lower levels. For men, the curve was U-shaped, with the highest mortality at the lowest cholesterol levels.
The Framingham Study found that falling cholesterol levels over 14 years predicted increased mortality in the following 18 years - an 11% overall and 14% cardiovascular death rate increase per 1mg/dl drop in cholesterol. Multiple large studies consistently show that after age 50, low cholesterol is significantly associated with greater mortality, with the risk increasing with age.
Women present a fundamental challenge to the cholesterol hypothesis: they have higher average cholesterol levels than men yet suffer far less heart disease - sometimes 300% less. The 1992 Conference on Low Blood Cholesterol found that among 124,818 women studied, there was "essentially flat relation of total cholesterol to total cardiovascular and total cancer mortality."
For decades, researchers attributed this to "protection" from female sex hormones, but this hypothesis collapsed under scrutiny. A 1963 study comparing women with and without ovaries showed identical heart disease rates. Later research confirmed "the normal menopause was not associated with any increase in risk of coronary heart disease."
HDL, the so-called "good cholesterol," is widely accepted as protective against heart disease, yet the evidence supporting this claim is remarkably thin. The HERS trial actually showed that as HDL levels rose, so did heart disease risk - a 3% increase for every 0.14mmol/l rise in HDL. Even more damning, a community in Limone sul Garda, Italy with extremely low HDL levels demonstrated extraordinary resistance to heart attacks.
Comparing British women with French men reveals another fatal contradiction. French men have worse conventional risk factors: they consume more saturated fat (15.5% vs 13.6%), have higher rates of hypertension (11% vs 7%), slightly higher cholesterol levels (5.7mmol/l vs 5.6mmol/l), and smoke more (31% vs 25%). Yet historically, British women have had higher heart disease rates.
Australian Aboriginal men have one of the world's highest heart disease rates (1,100 per 100,000/year) - four times the UK rate and ten times France's - yet their average cholesterol is just 4.9mmol/l compared to the UK's 6.1mmol/l. The MONICA study data shows complete dissociation between cholesterol levels and heart disease across populations - Swiss men have the highest cholesterol but nearly the lowest heart disease rate, while Russians have the second lowest cholesterol but highest heart disease in Europe.
Capítulo 7
Statins: Modest Benefits, Serious Risks
Statins lower LDL levels and supposedly protect against heart disease - the ultimate "proof" of the cholesterol hypothesis. Yet even when LDL is reduced to 2mmol/l, heart disease risk only drops by about 30% maximum, meaning the supposed causal factor can be virtually eliminated while the disease persists.
The Framingham risk calculator creates an illusion of precision in heart disease prediction, using factors like sex, age, cholesterol, smoking status, HDL, and blood pressure. Yet its accuracy varies wildly across populations - it overestimates risk by 400% in French men and underestimates risk by up to 3,000% in young Aboriginal women. In the UK, 84% of heart disease occurred in men classified as "low risk" while 75% of "high risk" men remained disease-free after ten years.
Despite glowing endorsements from prestigious sources claiming statins could save thousands of lives, critical analysis reveals troubling inconsistencies. The uncomfortable truth: statins do not save lives in women, period. They may change what appears on a death certificate but won't change the date. Yet doctors continue prescribing these powerful drugs to millions of women, with potential dangers including severe birth defects when taken during pregnancy.
For men, statin benefits depend entirely on pre-existing heart conditions. Men with diagnosed heart disease show reduced cardiovascular events and mortality when taking statins. However, for men without heart disease - over 90% of the male population - statins provide zero mortality benefit despite reducing cardiovascular events. The University of British Columbia's Cochrane collaboration concluded that "statins have not been shown to provide an overall health benefit in primary prevention trials."
Despite pharmaceutical industry claims of safety, statins present concerning health risks. Cognitive impairments represent one of the most troubling effects. Dr. Duane Graveline, a physician and former NASA astronaut, experienced severe episodes of memory loss and transient global amnesia after taking statins. The brain contains 25% of the body's cholesterol, and research revealed cholesterol as the "magic ingredient" enabling synapse formation between neurons.
Other significant risks include polyneuropathy (patients taking statins for 2+ years showed a 26.4-fold increased risk), muscle damage (some experts estimate 15-20% of patients experience pain or weakness), and potential cancer risk (all major lipid-lowering drugs cause cancer in rodents at exposure levels similar to human dosing).
Heart failure represents another serious concern. Statins block not just cholesterol synthesis but also coenzyme Q10 production, a substance critical for cellular energy production, especially in heart muscle. Some cardiologists believe the current rise in heart failure across the Western world directly results from statin use.
While statins do reduce mortality in men with existing heart disease, the benefits are modest. The 4S trial showed a 3.3% absolute risk reduction over five years (0.66% annually), while WOSCOPS showed just 0.9% reduction over five years (0.18% annually). Claims of "saving lives" are misleading - statins merely delay death, increasing average lifespan by approximately two months over thirty years of use, and only for men with pre-existing heart disease.
Capítulo 8
The True Cause of Heart Disease: Stress and Social Disruption
After dismissing the cholesterol hypothesis, what actually causes heart disease? The primary culprit appears to be stress - specifically, dysfunction in the hypothalamus-pituitary-adrenal axis (HPA-axis) that governs our stress response. This system involves hormones like adrenaline, cortisol, growth hormone and glucagon on the stress side, with insulin dominating the relaxation side.
The HPA-axis works with the autonomic nervous system, which has sympathetic ("fight or flight") and parasympathetic (digestive/relaxation) divisions. The sympathetic system speeds heart rate, releases glucose, and triggers clotting factors, creating a catabolic state ready to burn energy. The parasympathetic system does the opposite, slowing heart rate and promoting digestion.
A dysfunctional HPA-axis can result from various causes, including tumors. Cushing's disease - caused by a pituitary tumor secreting excess ACTH - increases cortisol levels dramatically, triggering multiple metabolic effects: glucose release from the liver, breakdown of fat stores, protein breakdown in muscles, and insulin resistance. This leads to high blood sugar, diabetes, muscle loss, and redistribution of fat from limbs to abdomen.
People with Cushing's disease also develop raised VLDL/LDL, low HDL, high blood pressure, and elevated clotting factors - all increasing heart attack risk. Similarly, long-term steroid users develop the same metabolic abnormalities and dramatically increased heart disease risk.
Depression significantly increases heart disease risk through similar HPA-axis abnormalities. Studies show depressed individuals develop visceral fat accumulation, demonstrating that visceral fat isn't simply genetic but results from HPA-axis dysfunction and cortisol disturbances. Treating depression often reverses these metabolic abnormalities.
The final link between HPA-axis dysfunction and heart disease involves the "response to injury" hypothesis. Plaques begin as small areas of endothelial damage, which normally heal through thrombus formation and endothelial re-growth. Factors that accelerate plaque growth include those that damage the endothelium or cause more dangerous blood clots to form - high blood sugar, high insulin, acute mental stress, smoking, cocaine, cortisol, and high adrenaline.
Capítulo 9
Social Dislocation: The Hidden Epidemic
The stress hypothesis explains the enormous variations in heart disease rates worldwide. The key stressor affecting entire populations appears to be "social dislocation" - the disruption of community bonds and social networks through forced migration, cultural destruction, or massive societal change.
Finland had the world's highest heart disease rate in the 1960s-70s following what was proportionally the greatest forced relocation in European history. After WWII, Russia claimed a large part of Finland called Karelia, forcing 400,000 Finns to relocate. The North Karelia region, where most displaced people settled, subsequently had Finland's highest heart disease rates.
Scotland, particularly Glasgow, had the world's highest heart disease rates in the 1970s-80s following massive social engineering. In 1946, planners decided to relocate 550,000 Glaswegians from tenements to new towns and high-rise flats. While the tenements were physically poor, they fostered strong community bonds. The replacement housing destroyed these community connections, leading to "social exclusion and despair."
Conversely, Roseto, Pennsylvania, a community of Italian immigrants primarily from Sicily, demonstrated remarkably low heart disease rates despite migration to a new country. A 50-year study found Rosetans maintained lower myocardial infarction mortality rates than neighboring towns for 30 years, but these protective effects disappeared as the community became more "Americanized" with the erosion of "traditionally cohesive family and community relationships."
The Japanese have low heart disease rates, but lose this protection when migrating to other countries - not because of dietary changes, but because of cultural disruption. Japanese-Americans who maintain traditional Japanese culture and lifestyle have heart disease rates as low as those in Japan, while those who adopt Western culture show three to five times higher rates.
Those lower in social hierarchies face greater heart disease risk across species. Studies of macaque monkeys show submissive animals develop more extensive coronary artery disease than dominant ones. The Whitehall Study demonstrates civil servants in lower-ranking positions suffer more heart disease than higher-ranked colleagues, primarily due to lack of job control.
Women typically develop heart disease about ten years later than men for three interconnected reasons: women are generally less hostile/aggressive, better at developing social support networks, and respond physiologically differently to stressors. Research confirms men report significantly less social support than women across all social classes. Men also have more violent HPA-axis reactions to stress, producing nearly twice as much ACTH when stressed.
Capítulo 10
Practical Solutions for a Healthy Heart
Kendrick presents comprehensive, evidence-based strategies to prevent heart disease that focus on lifestyle and psychological wellbeing rather than medication:
1. Don't smoke - Smoking not only damages blood vessels directly but dramatically activates the HPA-axis stress response system, increasing blood clotting factors and inflammatory markers. Even occasional smoking can trigger these harmful physiological changes that persist for hours after exposure. The good news is that these effects begin reversing within days of quitting.
2. Exercise regularly through enjoyable activities - While exercise is crucial for heart health, forced or unpleasant exercise routines can actually create additional stress. The key is finding physical activities you genuinely enjoy, whether it's dancing, gardening, walking with friends, or playing sports. The social and pleasure aspects of exercise multiply its protective effects.
3. Drink alcohol moderately and socially - Research shows that moderate alcohol consumption (1-2 drinks daily) in social settings provides cardiovascular protection. This benefit appears linked more to the social context than the alcohol itself. The key is moderation - excessive drinking negates any potential benefits and increases heart risks.
4. Avoid toxic work environments - Chronic workplace stress, especially from controlling or bullying supervisors, creates persistent physiological strain that damages cardiovascular health over time. Studies show that people who stay in jobs they hate have significantly higher rates of heart attacks. When possible, prioritize work environments that feel supportive and meaningful.
5. Cultivate strong social connections - Regular social interaction and maintaining close relationships provide powerful protection against heart disease. Join community groups, maintain friendships, participate in team activities, and prioritize family connections. Research shows that social isolation is as damaging as smoking for heart health.
6. Find daily sources of joy and meaning - Positive emotions help regulate the HPA-axis and reduce inflammation. Simple daily pleasures like music, nature, creativity, or time with loved ones create physiological benefits. Having a sense of purpose and meaning in life correlates with better cardiovascular outcomes.
The medical establishment has long maintained an artificial divide between mind and body, often dismissing psychological factors as "soft" science despite mounting evidence of their impact. Modern research techniques now allow us to measure how mental states directly affect inflammation, blood clotting, and arterial health.
The cholesterol hypothesis has dominated heart disease prevention for decades, leading to widespread statin prescriptions while overlooking crucial psychological and social factors. While managing cholesterol through medication may help some high-risk patients, population-level heart health requires addressing deeper causes: chronic stress, social disconnection, and the erosion of community support systems. By fixating on cholesterol numbers, we've created a medicated society that ignores the fundamental drivers of cardiovascular disease.
The solution lies not in more medications but in rebuilding social connections, reducing chronic stress, and creating environments that support psychological wellbeing. These factors have measurable biological effects that directly impact heart health through multiple pathways including inflammation, blood pressure regulation, and clotting factors.
